Dr. Woreta joins Johns Hopkins from Texas Tech University Health Sciences Center, where she was the interim chief of the division of gastroenterology. Specializing in acute and chronic liver diseases, she sees patients with viral hepatitis, alcoholic liver disease, nonalcoholic fatty liver disease and those in need of cirrhosis liver transplantation. Dr. Woreta has authored several publications and chapters. She is board certified in internal medicine, gastroenterology and transplant hepatology.

Hepatocellular Carcinoma; Liver Transplantation Outcomes; Chronic Viral Hepatitis

Kim B, Woreta T, Chen PH, Limketkai B, Singer A, Dagher N, Cameron A, Lin MT, Kamel I, Gurakar A. Donor-Transmitted Malignancy in a Liver Transplant Recipient: A Case Report and Review of Literature. Dig Dis Sci. 2012: Epub ahead of print. Woreta TA, SutcliffeCG, MehtaSH, BrownTT, HigginsY, ThomasDL, TorbensonMS, MooreRD, SulkowskiMS. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology. 2011; 140: 809-817. Woreta TA, Feldman LS, Stewart RW. Exotic Origin, Familiar Culprit. Am J Med. 2010; 123(3): 220-2. Woreta TA, Munoz BE, Gower EW, Alemayehu W, West SK. Effect of trichiasis surgery on visual acuity outcomes in Ethiopia. Arch Ophthalmol. 2009; 127(11): 1505-10. Rybak EA, Polotsky AJ, Woreta T, Hailpern SM, Bristow RE. Explained Compared with Unexplained Fever in Postoperative Myomectomy and Hysterectomy Patients. Obstet Gynecol. 2008; 111(5): 1137-42. Syin D, Woreta TA, Chang DC, Cameron JL, Pronovost PJ, Makary MA. Publication Bias in Surgery: Implications for Informed Consent. J Surg Res. 2007; 143(1): 88-93. Poliquin K, Ershov YV, Cunningham FX Jr., Woreta TA, Gantt RR, Gantt E. Inactivation of sll1556 in Synechocystis Strain PCC 6803 Impairs Isoprenoid Biosynthesis from Pentose Phosphate Cycle Substrates In Vitro. J Bacteriol. 2004; 186(14): 4685-93.